(-)-Ternatin inhibits adipogenesis and lipid metabolism in 3T3-L1 cells

Peptides

Volumn 30, Issue 6, 2009, Pages 1074-1081

  Ito, Masahiko ^a   Ito, Junko ^a   Kitazawa, Hidefumi ^a   Shimamura, Ken ^a   Fukami, Takehiro ^a   Tokita, Shigeru ^a   Shimokawa, Kenichiro ^b   Yamada, Kaoru ^c   Kanatani, Akio ^a   Uemura, Daisuke ^c  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

( ) Ternatin; 3T3 L1 cells; Adipogenesis; Lipogenesis

Indexed keywords

ALANINE; CELL MARKER; CYCLOPEPTIDE; FAS ANTIGEN; MESSENGER RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TERNATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE MEMBRANE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; LIPID METABOLISM; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; FLAVONOIDS; HEPATOCYTES; LIPID METABOLISM; MALE; MICE; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIGLYCERIDES;

MUS; RATTUS;

EID: 67349217426     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.02.008     Document Type: Article

References (54)

1. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4 (1999) 585-595
2. Cao Z., Umek R.M., and McKnight S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5 (1991) 1538-1552
3. Cornelius P., Macdougald O.A., and Lane M.D. Regulation of adipocyte development. Annu Rev Nutr 14 (1994) 99-129
4. Darlington G.J., Ross S.E., and MacDougald O.A. The role of C/EBP genes in adipocyte differentiation. J Biol Chem 273 (1998) 30057-30060
5. Duvnjak M., Lerotic I., Barsic N., Tomasic V., Jukic L.V., and Velagic V. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol 13 (2007) 4539-4550
6. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab 4 (2006) 263-273
7. Farrell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99-S112
8. Franssen R., Monajemi H., Stroes E.S.G., and Kastelein J.J.P. Obesity and dyslipidemia. Endocrinol Metab Clin North Am 37 (2008) 623-+
9. Fruhbeck G., Gomez-Ambrosi J., Muruzabal F.J., and Burrell M.A. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol-Endocrinol Metab 280 (2001) E827-E847
10. Fruhbeck G. Overview of adipose tissue and its role in obesity and metabolic disorders. Methods Mol Biol 456 (2008) 1-22
11. Fujimori K., Aritake K., and Urade Y. A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c. J Biol Chem 282 (2007) 18458-18466
12. Harada N., Oda Z., Hara Y., Fujinami K., Okawa M., Ohbuchi K., et al. Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice. Mol Cell Biol 27 (2007) 1881-1888
13. Harmon A.W., and Harp J.B. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am J Physiol-Cell Physiol 280 (2001) C807-C813
14. Im S.S., Kwon S.K., Kang S.Y., Kim T.H., Kim H.I., Hur M.W., et al. Regulation of GLUT4 gene expression by SREBP-1c in adipocytes. Biochem J 399 (2006) 131-139
15. Ito M., Gomori A., Ishihara A., Oda Z., Mashiko S., Matsushita H., et al. Characterization of MCH-mediated obesity in mice. Am J Physiol-Endocrinol Metab 284 (2003) E940-E945
16. Juvet L.K., Andresen S.M., Schuster G.U., Dalen K.T., Tobin K.A., Hollung K., et al. On the role of liver X receptors in lipid accumulation in adipocytes. Mol Endocrinol 17 (2003) 172-182
17. Kaluzny M.A., Duncan L.A., Merritt M.V., and Epps D.E. Rapid separation of lipid classes in high-yield and purity using bonded phase columns. J Lipid Res 26 (1985) 135-140
18. Kasturi R., and Wakil S.J. Increased synthesis and accumulation of phospholipids during differentiation of 3T3-L1-cells into adipocytes. J Biol Chem 258 (1983) 3559-3564
19. Kim J.K., So H., Youn M.J., Kim H.J., Kim Y., Park C., et al. Hibiscus sabdariffia L. water extract inhibits the adipocyte differentiation through the P13-K and MAPK pathway. J Ethnopharmacol 114 (2007) 260-267
20. Kim N.H., Choi S.K., Kim S.J., Moon P.D., Lim H.S., Choi I.Y., et al. Green tea seed oil reduces weight gain in C57BL/6J mice and influences adipocyte differentiation by suppressing peroxisome proliferator-activated receptor-γ. Pflugers Arch: Eur J Physiol 457 (2008) 293-302
21. Kobilka B. Adrenergic-receptors as models for G protein-coupled receptors. Annu Rev Neurosci 15 (1992) 87-114
22. Koutnikova H., Cock T.A., Watanabe M., Houten S.M., Champy M.F., Dierich A., et al. Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice. Proc Natl Acad Sci USA 100 (2003) 14457-14462
23. Langhans W. Role of the liver in the control of glucose-lipid utilization and body weight. Curr Opin Clin Nutr Metabolic Care 6 (2003) 449-455
24. Macdougald O.A., and Lane M.D. Transcriptional regulation of gene-expression during adipocyte differentiation. Annu Rev Biochem 64 (1995) 345-373
25. Madsen L., Petersen R.K., Sorensen M.B., Jorgensen C., Hallenborg P., Pridal L., et al. Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process. Biochem J 375 (2003) 539-549
26. Mann C.C. Public health. Provocative study says obesity may reduce U.S. life expectancy. Science 307 (2005) 1716-1717
27. Maxwell K.N., Soccio R.E., Duncan E.M., Schayek E., and Breslow J.L. Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. J Lipid Res 44 (2003) 2109-2119
28. Mcgowan M.W., Artiss J.D., Strandbergh D.R., and Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29 (1983) 538-542
29. Miyamoto S., Yasui Y., Tanaka T., Ohigashi H., and Murakami A. Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice. Carcinogenesis 29 (2008) 1057-1063
30. Mizuarai S., Miki S., Araki H., Takahashi K., and Kotani H. Identification of dicarboxylate carrier Slc25a10 as malate transporter in de novo fatty acid synthesis. J Biol Chem 280 (2005) 32434-32441
31. Ogden C.L., Yanovski S.Z., Carroll M.D., and Flegal K.M. The epidemiology of obesity. Gastroenterology 132 (2007) 2087-2102
32. Parekh S., and Anania F.A. Abnormal lipid and glucose metabolism in obesity: Implications for nonalcoholic fatty liver disease. Gastroenterology 132 (2007) 2191-2207
33. Postic C., Dentin R., and Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab 30 (2004) 398-408
34. Rangwala S.M., and Lazar M.A. Transcriptional control of adipogenesis. Annu Rev Nutr 20 (2000) 535-559
35. Reaven G., Abbasi F., and McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Rec Progr Hormone Res 59 59 (2004) 207-223
36. Repa J.J., Liang G., Ou J., Bashmakov Y., Lobaccaro J.M., Shimomura I., et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev 14 (2000) 2819-2830
37. Rosen E.D., and Spiegelman B.M. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16 (2000) 145-171
38. Rosen E.D., Walkey C.J., Puigserver P., and Spiegelman B.M. Transcriptional regulation of adipogenesis. Genes Dev 14 (2000) 1293-1307
39. Saito T., Abe D., and Sekiya K. Nobiletin enhances differentiation and lipolysis of 3T3-L1 adipocytes. Biochem Biophys Res Commun 357 (2007) 371-376
40. Shimokawa K., Iwase Y., Miwa R., Yamada K., and Uemura D. Whole structure-activity relationships of the fat-accumulation inhibitor (-)-ternatin: recognition of the importance of each amino acid residue. J Med Chem 51 (2008) 5912-5914
41. Shimokawa K., Iwase Y., Yamada K., and Uemura D. Synthesis and inhibitory effect on fat accumulation of (-)-ternatin derivatives modified in the beta-OH-d-Leu(7) moiety. Org Biomol Chem 6 (2008) 58-60
42. Shimokawa K., Mashima I., Asai A., Ohno T., Yamada K., Kita M., et al. Biological activity, structural features, and synthetic studies of (-)-ternatin, a potent fat-accumulation inhibitor of 3T3-L1 adipocytes. Chem: Asian J 3 (2008) 438-446
43. Shimokawa K., Mashima I., Asai A., Yamada K., Kita M., and Uemura D. (-)-Ternatin, a highly N-methylated cyclic heptapeptide that inhibits fat accumulation: structure and synthesis. Tetrahedron Lett 47 (2006) 4445-4448
44. Shimokawa K., Yamada K., Kita M., and Uemura D. Convergent synthesis and in vivo inhibitory effect on fat accumulation of (-)-ternatin, a highly N-methylated cyclic peptide. Bioorg Med Chem Lett 17 (2007) 4447-4449
45. Spiegelman B.M., Flier J.S., and Adipogenesis. Obesity: rounding out the big picture. Cell 87 (1996) 377-389
46. Sugimoto Y., Naniwa Y., Nakamura T., Kato H., Yamamoto M., Tanabe H., et al. A novel acetyl-CoA carboxylase inhibitor reduces de novo fatty acid synthesis in HepG2 cells and rat primary hepatocytes. Arch Biochem Biophys 468 (2007) 44-48
47. Tamura Y., Tanaka Y., Sato F., Choi J.B., Watada H., Niwa M., et al. Intracellular lipid accumulation and insulin resistance in skeletal muscle and liver. Jpn J Phys Fitness Sports Med 56 (2007) 34
48. Trayhurn P., and Beattie J.H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60 (2001) 329-339
49. Unger R.H. Lipotoxicity in the pathogenesis of obesity-dependent Niddm - genetic and clinical implications. Diabetes 44 (1995) 863-870
50. Wu Z.D., Rosen E.D., Brun R., Hauser S., Adelmant G., Troy A.E., et al. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 3 (1999) 151-158
51. Yamamoto T., Shimano H., Inoue N., Nakagawa Y., Matsuzaka T., Takahashi A., et al. Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver. J Biol Chem 282 (2007) 11687-11695
52. Yasufumi N., Yusuke H., Fumiaki I., and Toshio K. Effect of simvastatin (MK-733) on the regulation of cholesterol synthesis in Hep G2 cells. Biochem Pharmacol 40 (1990) 843-850
53. Yeh W.C., Cao Z., Classon M., and McKnight S.L. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9 (1995) 168-181
54. Yoshikawa T., Shimano H., Amemiya-Kudo M., Yahagi N., Hasty A.H., Matsuzaka T., et al. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol Cell Biol 21 (2001) 2991-3000